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Abstract
A huge amount of atomized biological data collected in various databases and the need for
a description of their relation by theoretical methods causes the development of data inte-
gration methods. The omics data analysis by integration of biological knowledge with mathe-
matical procedures implemented in the OmicsON R library is presented in the paper.
OmicsON is a tool for the integration of two sets of data: transcriptomics and metabolomics.
In the workflow of the library, the functional grouping and statistical analysis are applied.
Subgroups among the transcriptomic and metabolomics sets are created based on the bio-
logical knowledge stored in Reactome and String databases. It gives the possibility to ana-
lyze such sets of data by multivariate statistical procedures like Canonical Correlation
Analysis (CCA) or Partial Least Squares (PLS). The integration of metabolomic and tran-
scriptomic data based on the methodology contained in OmicsON helps to easily obtain
information on the connection of data from two different sets. This information can signifi-
cantly help in assessing the relationship between gene expression and metabolite concen-
trations, which in turn facilitates the biological interpretation of the analyzed process.
Introduction
Technologies of molecular biology providing a big amount of data have given rise to large-
scale biological datasets. Analysis of such data imposes methodological challenges relating to
the complex structure and the size of the data. Driven by high-throughput omics technologies
and the computational surge, it enables multi-scale and insightful overviews of cells, organ-
isms, and populations. This approach has had a huge impact on the discovery of next-genera-
tion diagnostics, biomarkers, and drugs in the precision medicine era [1].
Systemic exploration of complex interactions in biological systems because of the develop-
ment of new technologies and analytical methods allows the creation of clinically useful tools
[2]. Despite their promise, the translation of these technologies into clinically actionable tools
has been slow [3] [4] [5]. This is due to the complexity of the issues, but also with the problems
arising from the data standardization, data sharing, storing Omics data appropriately and
exploring Omics data [6]. Proper organizing and standardizing data, as well as newly
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In this paper, data analysis by integrative biological knowledge (from biological databases)
with mathematical procedures (multidimensional statistical analysis) developed in the Omic-
sON library is presented. The procedure implemented in the OmicsON library is based on a
previously developed and published algorithm [14].
Design and implementation
The OmicsON library was written in R language [15] according to the Bioconductor guide-
lines. Particular steps analysis were described based on the lipidomics and transcriptomic data
[16]. The standardization and evaluation, as well as the quality control of the data sets, is
beyond the functionality of the OmicsON library. It is assumed that pre-processing data is
done before analysis in OmicsON (because of different types of e.g. microarray technologies
and data formats).
The transcriptomics and lipidomics analysis based on the OmicsON library follow as on
the diagram is presented (Fig 1). The workflow in OmicsON consists of a functional pathway
and network analysis, statistical analysis by using Canonical Correlation Analysis and Partial
Least Square regression. The significant associations between lipidomic and transcriptomic
data are calculated. In this way, the researcher receives a set of information for substantive
assessment.
Data input
Input data is a set of transcriptomic and lipidomic data that were previously prepared, i.e. nor-
malized, and on which quality control was carried out. Variable distributions should be multi-
dimensional normal. As input, the library expects two matrices to be stored in a text file (tab-
delimited): transcriptional and lipidomic sets (fatty acids). The transcriptomic set in the col-
umns should contain the gene symbols according to the HGNC nomenclature [17] and in the
lines the levels of gene expression for the individual samples. In the metabolomics dataset in
the columns should be the metabolites identifiers according to the CHEBI nomenclature [18]
and in the lines should be quantitative data, eg metabolite concentrations.
Gene mapping and grouping data
Gene mapping is a step in which data are decorated by searching for ontologically related mol-
ecules present in Reactome’s pathways [19]. Results from the Reactome step are decorated by
extra interactions of genes based on knowledge taken from the STRING [20] database. Infor-
mation from the Reactome and the STRING databases gives the possibility for reducing the
size dimension of big gene transcription datasets. Finally, it obtains a broad list of potential
interactions to be sifted later by statistical testing with two goals: to minimize potential bias
towards well-characterized biochemical pathways and, at the same time, to propose new puta-
tive links relevant for the specific study (tissue, conditions).
OmicsON allows the mapping of HGNC, Ensemble, and UniProt gene identifiers to find
relationships in paths deposited in Reactome database (data sets in supplementary materials:
S1 Table).
Enrichment of information on sets of genes associated with fatty acids can be performed
for subsets of fatty acids (grouping data) [21]. Grouping data can be done before or/and after
gene mapping. For example, the correlation analysis of many thousands of transcriptomic data
(microarrays) among a few (or even several dozens) samples with metabolomics data are
PLOS ONE OmicsON – Library for omics data integration
PLOS ONE | https://doi.org/10.1371/journal.pone.0235398 July 29, 2020 2 / 13
scientific community. The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
difficult to carry out and in many cases impossible based on known statistical techniques. In
the case of classical canonical correlation analysis, the use of such a large matrix for correlation
with a metabolic set is not feasible. In such cases, it is justified to divide the data into subgroups
according to justified criteria.
The division into subsets of fatty acids and genes has not been automated in OmicsON.
Anyone can make such a breakdown according to criteria that can be different depending on
the analytical approach.
Statistical methods
Subgroups of gene and metabolite sets are analyzed with Canonical Correlation (CCA) [22]
and Partial Least Squares (PLS) [23] multivariate procedures. These two mathematical meth-
ods can be both used for the same datasets (subgroups) or can be used separately depending
on the dimension of the datasets (PLS is free of dataset dimension limits).
Canonical Correlation Analysis (CCA). The canonical analysis is a generalization of multi-
ple regression (regression analysis of many independent variables {X1,. . ., Xk} into one dependent
Y) into two sets of variables, i.e. a set of independent variables {X1,. . ., Xk} and a set of dependent
variables {Y1,. . ., Ym}. CCA allows you to find the answers to the following questions:
• What is the influence of the group of independent variables on the group of effect variables
(dependent)? In our case, independent variables {X1,. . ., Xk}—expressions for the group of
dependent variables {Y1,. . ., Ym}—lipidomics.
Fig 1. The workflow of lipidomics (metabolomics) and transcriptomics data integration. Light gray means steps performed outside and the dark gray steps performed
using the OmicsON library.
https://doi.org/10.1371/journal.pone.0235398.g001
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• Is, and if so, which of the independent variables {X1,. . ., Xk} explains the possibly highest
range of variability in the area of the set of dependent variables {Y1,. . ., Ym}?
• Will the introduction of additional (new) variables independent or dependent on the ana-
lyzed sets affect the value of the total variance (increase its value)?
• Which variables from the set of variables {X1,. . ., Xk} jointly explain the largest range of vari-
ation within the group of variables {Y1, Y2,. . ., Ym}?
The canonical correlation allows assessing whether variables from one data set can be used
to predict another set of data by finding such a linear combination of variables from the first
set so that it correlates as strongly as possible with variables from the second set. It boils down
to finding the vectors of coefficients (a1, a2. . . ap) and (b1, b2. . . bq) such that the correlation
cor(a’X; b’Y) would be as large as possible. Thanks to this, new variables are created, so-called
hidden or canonical variables, i.e. u1 = a’X; v1 = b’Y, which explains a significant part of the
variability between the analyzed sets.
In the next steps, hidden variables are found, i.e. ui = aiX; vi = biY with the largest correla-
tions cor(ui; vi). The designated hidden variables are a measure of the correlation between the
sets {X1,. . ., Xk} and {Y1,. . ., Ym} and their weighted sums.
In the canonical analysis, the selection of canonical variability coefficients for particular var-
iables is crucial in such a way that the two weighted sums (a1X1 + a2X2 +. . . + apXk and b1Y1
+ b2Y2 +. . . + bqYm) were maximally correlated. The structure of variables and their specific
contribution is reflected precisely by canonical weights. The higher the value (positive or nega-
tive) of the scale, the larger the contribution of a given variable to the canonical variable.
Canonical weights are often given for standardized variables (mean = 0, standard deviation = 1),
which facilitates their evaluation (comparison). These weights can be interpreted as beta coeffi-
cients in multiple regression. Correlations between hidden variables are called canonical corre-
lation. A low canonical correlation or lack of it may indicate a wrong model or lack of
connections between the analyzed two sets of variables. The interpretation of canonical corre-
lations cannot be interpreted in the same way as Pearson’s correlation. In the case of canonical
analysis, this is only an auxiliary coefficient showing the extent to which the pair of weighted
sums have been linked (correlated).
In the canonical analysis, correlations between canonical variables and variables in each
group of variables are also determined. They are the so-called canonical factor loadings. The
greater the value of the factor charge, the larger the contribution of the canonical variable. The
value of factor charges elevated to the square represents the proportion of the variance of a
given variable explained by the canonical variable (interpretation similar to the coefficient of
determination). The average calculated for a given canonical variable after all variables give
information about how many percent of the variance is explained by the given canonical vari-
able on average. This is called variance on fractional variance deposition on canonical variates.
In a canonical analysis, there is a parameter called redundancy. It is calculated by increasing
the canonical correlation to the square and multiplying by the variances calculated for the set
of independent variables {X1,. . ., Xk} For example, if the redundancy of the first canonical var-
iable {X1,. . ., Xk} is 0.76, it means that this variable explains 76% of the variation in the set
{Y1,. . ., Ym}.
Summing up, the canonical analysis consists in:
• finding hidden variables.
• canonical variables that are not correlated with each other, which give information about
specific variability in two data sets.
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• calculation of canonical weights describing the pure contribution of each variable to the
canonical variable.
• calculation of factor loads determining the correlation of each variable with the canonical
variable.
• calculation of the redundancy (by calculating the variance) that tells how much the average
variance of one set is explained by the given canonical variable by means of the variables of
the second set of data.
The classic canonical correlation has many limitations including:
• variable distributions should be multidimensional normal.
• variables in collections should not be collinear (data redundancy prevents reliable presenta-
tion of results). This dependence allows capturing the correlation matrix.
• the outlying points should be rejected because the canonical analysis is very sensitive to
them.
• it is recommended to use at least 20 times as many elements of the sample group as variables
for the analysis.
Partial Least Squares regression (PLS). Partial Least Squares Regression (PLS), like
canonical correlation, is used to estimate the relationship between lipidomic and transcrip-
tomic data. The practical difference between the application of canonical analysis and the par-
tial Least Squares Regression is mainly based on other initial assumptions. No rejection of
correlated dependent and independent variables is required, and the number of observations
may be smaller than the number of predictors. Therefore, PLS is used in the exploratory analy-
sis to choose convenient predictors and to identify outliers.
The PLS method (often referred to as "latent mapping") combines features of principal
component analysis and multiple regression. First, it extracts a set of latent factors that explain
as many covariances as possible between independent and dependent variables (a covariance
matrix is created). Then, the values of dependent variables are predicted using the decomposi-
tion of independent variables. The PLS method is particularly useful when predictors are
highly correlated (variables X) or when the number of variables is greater than the number of
observations. PLS can be used in situations where the use of traditional multidimensional
methods is severely limited. PLS is the least restrictive extension of the linear multiple regres-
sion model, which is also the basis for many other multidimensional methods. PLS can be
used in situations where the use of traditional multidimensional methods are not effective.
The constraints that are not imposed by the PLS method are: (1) factors reflecting variables
from the set Y and X are extracted based on the matrix Y’Y and X’X, respectively, and not
based on the matrix of mixed products concerning both the variables from the set Y and from
the set X and (2) the number of prognostic functions never exceeds the minimum from the
number of variables from the set Y and X. In the case of PLS, prognostic functions are repre-
sented by factors determined based on the matrix Y’XX’Y. The number of such prognostic
functions that can be determined usually exceeds the maximum from the number of Y and X
variables. PLS can be used as a mining analysis tool to select prediction variables (it finds sets
of independent variables) and to find outliers before applying classical linear regression.
The purpose of PLS (partial least-squares regression) is to build a linear model in the form
Y = XB + E where:
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Y—matrix of variable relationships with dimensions n (number of cases) per m (number of
variables), X—matrix of independent variables with dimensions n (number of cases) per k
(number of variables), B—matrix of regression coefficients with dimensions k on m, E is a
random component of a model with dimensions such as the Y matrix.
In the PLS procedure, factorial values are calculated as linear combinations of non-conver-
gent variables (predictors) in such a way that there is no correlation between variables of factor
values used in the prognostic regression model.
An important step in the PLS analysis is to check the significance of latent variables with
cross-validation. For example, take a set of response data (dependent variables Y) and predic-
tors (independent variables X), which can be in part significantly correlated with each other.
For such data, the matrix of factor values T = XW (W—the matrix of weights) is determined
and then the linear regression model Y = TQ + E (Q—matrix of regression coefficients
(loads)) can be used. The weight matrix W reflects the covariance structure between indepen-
dent variables (predictors) and dependent variables (responses) in that it maximizes the
covariance between dependent variables and the corresponding factor values. Next, the least-
squares method determines the Y-regression against T for determining the Q matrix with
charges (weights) for Y such that Y = TQ + E. When calculating the values of charges, the
equation Y = XB + E (B = WQ) is obtained, which serves as a prognostic regression model.
In the PLS procedure, a matrix of factor charges P is also obtained, which allows obtaining
factor model X = TP + F (F—unexplained part of X results). The regression of partial least
squares is a very efficient analytical method of intra-dimensional data, however, in the case of
biological data, it is not always sufficiently effective to draw biological conclusions from the
point of view.
The OmicsON library includes a PLS calculation library that enumerates all of the above
operations. In addition to basic information on the percentage of explained variations, the pro-
cedure provides the values of individual factor matrices, weights and regression coefficients,
residues and model fit results necessary to assess the correctness of the predictive model and
the correct interpretation of the final results. The cross-validation procedure for prediction of
the variable matching error i.e. RMSEP (root mean squared error of prediction), MSEP (mean
squared error of prediction) or R2 (coefficient of multiple determination) is applied in the PLS
library. The error evaluation allows for the proper selection of variables in the model so that
they best describe the analyzed process.
Biological interpretation
Reducing the dimensions of two data sets and obtaining hidden variables (CV in the case of
CCA and LV in the case of PLS) allows the observation of relationships between two sets of
variables, transcriptomic and metabolic in this case. Relating gene expression with fatty acids
pave the way for the biological interpretation of such a dependence. Thanks to this, often
unobvious relationships of two sets of variables explain or show the direction of the course of
the analyzed biochemical processes.
Results
As an example application of the OmicsON library, sets of fatty acids and gene transcription
from a collection of murine nutrigenomics study was used [24]. The population comprises
mice nurtured in five different diet regimes, with 40 individuals in total. Based on the analysis
of hepatic samples (four biological replicates at three-time points each), it comprises gene
expression data of 120 selected genes potentially involved in lipid metabolism and
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concentrations of 21 fatty acids. This is not a large data set, but sufficient to demonstrate the
functionality of the OmicsON library.
The purpose of the analysis was to check (with CCA and PLS) between which variables, i.e.
genes (transcripts) versus fatty acids (metabolites) there is an association.
Gene mapping
In the first step, the gene mapping procedure was performed based on knowledge from Reac-
tome [25]. For each class of fatty acids for a given list of small molecule ChEBI identifiers [26],
associated reactions in the Reactome database were found. All genes found in this set of reac-
tions define a group of genes initially associated with a given class of fatty acids. In the case
where ChEBI’s id is presented in ChEBI2Reactome.txt (automatically taken by the OmicsON
library from the Reactome database) file then the mapping is taken from that file. When we
cannot find that our ChEBI’s id is presented in this file, then we search the ChEBI’s ontology
tree. We use a function which favoring children nodes, the closest child is taken as representa-
tive. Of course, the used child node should be presented in the mentioned mapping file. In the
case where no children are presented, then closest parent is taken. ChEBI’s ids without any
representation are not considered under further analysis.
In the next step, the list of genes was decorated by genes taken from the STRING database
[27]. A set of genes from the previous step is used to build a query in the STRING database via
the STRINGdb Bioconductor library [28]. This group of genes is expanded to include the clos-
est neighbors of these genes found in the gene interaction network to find interacting proteins
and associations between genes (Table 1).
As a result, a subset of genes functionally related to a set of fatty acids was obtained.
Autocorrelation in transcriptomic and lipidomic sets
Very often the number of genes (variables) is much larger than the number of samples (obser-
vations). Canonical correlation is sensitive to the number of observations and thus the calcula-
tion of CCA is not possible with original sizes sets of data. The transcriptomic (set of genes)
and lipidomic (set of fatty acids) data of the sets were checked for internal correlations because
performing the canonical correlation requires the removal of correlated predictors (indepen-
dent, transcriptomic variables—X) and responses (independent lipidomic variables—Y) (sup-
plementary material S1 Data and S2 Data). The correlation threshold is set arbitrarily and is
Table 1. List of genes and fatty acids after functional grouping with REACTOME and STRING using.
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closely related to the data type. Representatives (under the cutoff of internal correlation) were
selected for further analysis (in supplement data), while the rest were taken into account only
at the stage of biological interpretation (Table 2).
Canonical correlation results
A properly prepared set of data was subjected to canonical correlation analysis, the essence of
which is to find such linear combinations of variables in the analyzed sets that the correlation
between them is as large as possible. In this case, the strength of the relationship between tran-
scriptomic and lipidomic variables is very high and statistically significant for the first hidden
variables. Obtained canonical correlations for the analyzed data were: CV1 = 0.967 (p = 3.23e-
09), CV2 = 0.94 (p = 4.016e-05), CV3 = 0.86 (p = 0.013). Significance assessment calculated
based on Bartlett’s Chi-Squared test.
The OmicsON library allows obtaining also many detailed information when calculating
canonical correlations such as Canonical Variate Coefficients, Structural Correlations (Load-
ings), Fractional Variance Deposition on Canonical Variates, Canonical Communalities (Frac-
tion of Total Variance Explained for Each Variable, Within Sets), Canonical Variate
Adequacies (Fraction of Total Variance Explained by Each CV, Within Sets), Redundancy
Coefficients (Fraction of Total Variance Explained by Each CV, Across Sets).
The rest of the manuscript focuses on discussing the first hidden variable.
The figure (helio plot) shows which of the lipids are correlated with gene expressions (Fig
2). The positive correlation represents the bars towards the outside of the inner circle, and the
negative correlation visualizes the bars facing inside. The height of the bar indicates the height
of the correlation coefficient. The higher the bar the higher the correlation, the lower the bar
the lower correlation. The analysis results for the first subgroup show that the gene expression:
very-low-density lipoprotein receptor (VLDRL) and proteoglycan 4 (PRG4) is positively corre-
lated with docosahexaenoic acid (28125) and an icosapentaenoic acid (28364), as well as nega-
tively correlated with icosatrienoic acid (36036), vaccenic acid (36023) and γ-linolenic acid
(28661). The strength of correlation in these cases is significantly higher compared to other
fatty acids and expression of genes. The high strength of a relationship is also observed for
enoyl-CoA delta isomerase 2 (ECI2) and cyclin-dependent kinase inhibitor 1A (CDKN1A)
with some fatty acids. The reduced gene expression level of ECI2 and CDKN1A correlates
with high levels of fatty acids, i.e. docosahexaenoic acid (28125) and an icosapentaenoic acid
(28364), and low concentrations of vaccenic acid (36023), γ-linolenic acid (28661).
Partial least squares regression results
The partial least squares regression analysis (PLS) as an alternative method of analysis of the
canonical correlation was performed. The purpose of this analysis was to find a linear combi-
nation of variables from the transcriptomic and lipidomic data sets with the regression method
to find the relationships (contributions) of the individual variables with each other. The PLS
procedure also allows grouping data sets taking into account the contribution of variables to
the description of the model.
Table 2. List of genes and fatty acids after turning off correlated data within individual sets. R correlation coeffi-
cient cut-offs were assumed arbitrarily. It was for genes: r = 0.6 and for fatty acids: r = 0.7.
Genes symbols (HGNC) lipids ID (CHEBI)
APOB, VLDLR, PSMB10, PRG4, CYP26A1, ECI2, NR1I2,
RXRG, CDKN1A, APOA1, NOS2, ABCB8
73705, 17268, 15756, 28842, 36023, 32425, 36036,
28661, 61204, 27432, 28364, 28125
https://doi.org/10.1371/journal.pone.0235398.t002
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The biological interpretation of the effect of all fatty acids on all genes is difficult from an
interpretative point of view, hence the set obtained after the functional analysis was included
in the PLS procedure. Several "percentage variances explained" for latent variables (LV) were
calculated based on the given data sets. The percentage of explained variation allows assessing
whether given sets of data satisfactorily describe relationships between variables. For a ten
latent variables the following percentage explained variabilities were: LV1 = 32.57%,
LV2 = 51.55%, LV3 = 63.77%, LV4 = 68.84%, LV5 = 75.63%, LV6 = 78.32%, LV7 = 80.91%,
LV8 = 83.10%, LV9 = 84.79%, LV10 = 86.00%. The second latent variable will explain over
50% of the variability of the analyzed data sets, and the sixth close to 80%.
In addition to “percentage explained variation”, several other statistics were calculated,
including regression coefficients, scores, loadings, loading.weight, Yscores, Yloadings, projec-
tion. They allow assessing the contribution (weight) of individual transcriptomic and lipido-
mic variables to the model. Having information about the input of individual variables, it can
be build models used for prediction. It enables the selection of variables based on the determi-
nation of the prediction error e.g. root mean squared error of prediction (RMSEP) and the
Fig 2. The canonical correlation results for one subset of transcriptomic and lipidomic data. Positive correlation
represented by bars directed to the outside of the circle, and a negative correlation towards the inside. The height of the
bars indicates the strength of the association.
https://doi.org/10.1371/journal.pone.0235398.g002
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selection of a latent variable for interpretation in the case of a specific variable. As an example,
the results of RMSEP for fatty acids are presented (Fig 3). The interpretation of the contribu-
tion of individual fatty acid variables can be interpreted based on latent variables for which the
prediction error is the smallest. The results obtained show that at the level of the first latent
variable, the largest contribution to the linear model of the relationship of fatty acids and genes
have fatty acids with the CHEBI identifiers: 61204, 36036, 28661, 32325, 73705, 28842, 28364,
28125 (Fig 3). The RMSEP calculated for them is the smallest.
Discussion
The OmicsON library is a tool for the integration of transcriptomic and metabolomic data.
The procedures implemented in the library allow for gene mapping based on databases, i.e.
Reactom and String, and for statistical analyzes, i.e. canonical analysis (CCA) and Partial least
squares regression (PLS). This approach provides information on the relationship between the
transcription level of specific genes and the level of metabolites. Correlating this information
can significantly help in the interpretation of biological processes analyzed.
The OmicsON library has many advantages, but also several limitations, both from biologi-
cal data and statistical methods. The results obtained based on the OmicsON library could be
almost fully trusted when you could be sure that the data sets, such as Reactome or String are
complete. Meanwhile, it is known that these databases are constantly replenished, but they still
do not fully provide a complete description of the relationship between molecules. For some
organisms, there are more descriptions and relatively few for others. The library gives satisfac-
tory results in the case of:
• studying the data of well-annotated species.
• access to reliable molecular networks to achieve a functional relationship between
individuals.
Fig 3. Cross-validated RMSEP curves for the fatty acid variables. The smaller the prediction error, the better the given variable is suitable for the predictive model.
https://doi.org/10.1371/journal.pone.0235398.g003
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• a well-functioning internet network, as some procedures require communication with exter-
nal databases
• grouping of metabolomic and transcriptomic data in such a way that canonical correlation
(CCA) can be used since CCA cannot be used for a large number of observations and a small
number of test samples.
Another disadvantage that can be encountered is the problem with the availability of two
sets of data (e.g. transcriptomic and metabolomic) from one organism. Available public reposi-
tories collect and provide data sets usually for one type of data, e.g. only transcriptomic or only
metabolomic data. To demonstrate all the functionalities of the OmicsON library, the authors
used (the only data set available at that time) that concerned the mouse. The results of calcula-
tions were demonstrated based on Reactom and String datasets for humans (without narrow-
ing to specific tissues) because the most complete data set is currently for human. This is an
inaccuracy, but we would like to emphasize that the goal was to demonstrate the full function-
ality and capabilities of the OmicsON library and not a detailed interpretation of concrete the
biological processes.
Availability and future directions
OmicsON is available from https://github.com/cmujzbit/OmicsON.
In omics-based studies, small support of biological samples is often observed. This is associ-
ated with the high costs of wet laboratory and sequencing as well as the difficult availability of
clinical samples. Researchers address this problem by selecting appropriate computational
methods. Classical statistics methods are not efficient in such cases, therefore the research chal-
lenge is to use appropriate extensions or combinations of these mathematical tools. This opens
new possibilities for an analysis of a large data sets with a small number of observations.
One of the most effective ways to achieve improved results is to combine basic statistical
techniques (also called gold standard methods) with innovative approaches like regulated
canonical analysis (rCCA) [29] or regularization and grouping data by GCA method [30][31].
This ensures effective analysis of data in which the number of variables significantly exceeds
the number of observations [29,32][12].
In the future, the OmicsON will be improved through the implementation of univariate
models, including multiple testing correction strategies, dimension reduction techniques [30],
and variable selection models [30] [33].
Supporting information
S1 Table. List of genes and lipids. CleanData_06_08—Full experiment data with correlation’s
threshold 0.6 for X and 0.8 for Y, CleanData_06_07- Full experiment data with correlation’s
threshold 0.6 for X and 0.7 for Y, Reactome_Ensemble_06_07- Experiment data cutoff to
Reactome pathways base on Ensemble IDs with correlation’s threshold 0.6 for X and 0.7 for Y,
Reactome_UniProt_08_09—Experiment data cutoff to Reactome pathways base on Ensemble
IDs with correlation’s threshold 0.8 for X and 0.9 for Y, String_Expand_Ensemble_06_07-
Experiment data cutoff to String relations base on Ensemble IDs with correlation’s threshold
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